MapLight Therapeutics (MPLT) Operating Expenses (2024 - 2025)
MapLight Therapeutics' (MPLT) quarterly Operating Expenses came in at $173.2 million in Q4 2025, up 660.35% year-on-year from $22.8 million in Q4 2024, and up 449.83% quarter-over-quarter from $31.5 million in Q3 2025.
MapLight Therapeutics (MPLT) Operating Expenses (2024 - 2025) Analysis & Trends
MapLight Therapeutics has disclosed Operating Expenses across 2 years of filings, most recently posting $173.2 million for Q4 2025.
- Operating Expenses for Q4 2025 came in at $173.2 million, up 660.35% year-over-year; the trailing twelve-month figure through Dec 2025 was $248.4 million (changed N/A YoY), and the FY2025 annual result was $169.1 million, up 103.85% from the prior year.
- Operating Expenses came in at $173.2 million for Q4 2025 at MapLight Therapeutics, up from $31.5 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $173.2 million in Q4 2025 to a low of $20.9 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | MapLight Therapeutics | 248.88 Mn | 248.88 Mn | - | 173.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 173.19 Mn |
| Sep 30, 2025 | 31.50 Mn |
| Dec 31, 2024 | 22.78 Mn |
| Sep 30, 2024 | 20.89 Mn |